In one small study published in 2009, Lions Mane showed promise in improving brain function in participants with mild cognitive impairments but who were otherwise healthy
Primary sarcopenia is mainly age-related, while secondary sarcopenia arises from conditions such as heart failure, kidney failure, malignancy, and chronic obstructive pulmonary disease
the objective of the study was to demonstrate the clinical efficacy of the composition of the present invention by dosing it once a day, in the weight loss of 5% or more in the first 12 weeks of treatment and a weight loss of 10% in the second 12 weeks
We check your Medicare benefits free, so you know your exact out-of-pocket cost upfront
From a batch of 58 compounds, three showed reproducible, concentration-dependent stimulation of receptor signaling (Figure 5)
Initial video visits start at $49, follow-up chat visits and additional video visits (if needed) are $49 each